ISPE

MARCH 29, 2023

For purpose of illustration used throughout this article, labels have been assigned to each CQA. July–August 2020). The QTPP describes elements of the product related to quality, safety, and efficacy, as shown in Table 1. Table 1: Linkage among patient consideration, product design, target attributes and CQAs. McMahon, R. Nosal, and T.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

For purpose of illustration used throughout this article, labels have been assigned to each CQA. July–August 2020). The QTPP describes elements of the product related to quality, safety, and efficacy, as shown in Table 1. Table 1: Linkage among patient consideration, product design, target attributes and CQAs. McMahon, R. Nosal, and T.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

AUGUST 30, 2022

In the long term, a collaboration between regulators and industry stakeholders to develop and implement harmonized guidelines for raw materials would help address flexibility challenges, prevent delays in implementing process improvements, and ensure that both regulator and industry resources are devoted to the most critical issues.

Documentation 52

Documentation FDA Packaging Communication 52